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Abstract
Background: Using the Framingham Heart Study data set provided for Genetic Analysis
Workshop 13, we defined the cigarette-use phenotype M for smokers to be the maximum number
of cigarettes-per-day (MAXCIG) reported over the longitudinal course of the study. Adjustments
were made for the significant covariates of gender and year of birth, and sib-pair based linkage
analysis was performed.
Results: The primary analyses, in which individuals with MAXCIG = 0 were considered to have
missing phenotype, resulted in modest linkage evidence, with LOD scores over 1 on chromosomes
5, 9, 13, 14, and 22.
Conclusions: While the results reported here do not indicate definitive evidence for linkage to
specific chromosomal regions, future studies may find it useful to include direct assessments of
maximum and quantitative cigarette use. In defining and analyzing quantitative or "maximum use"
phenotypes, the choice of how to handle individuals with MAXCIG = 0, or alternatively, individuals
who are substance-naive, is a crucial one for genetic studies of nicotine and other substance use.
In this study, the linkage results vary greatly depending on whether or not these "unexposed"
individuals are included in the analyses.
Background
Cigarette smoking is a leading cause of premature death
and is a serious public health concern. Past studies of
smoking behavior have considered a variety of smoking
phenotypes and found that while smoking-related traits
are complex, there is evidence for significant genetic influ-
ences on smoking behavior [1,2].
The Framingham Heart Study data set provided for
Genetic Analysis Workshop 13 (GAW13) includes longi-
tudinal data on daily cigarette use. In the past the Fram-
ingham data have been used to study important cigarette
smoking patterns such as cessation and resumption [3].
Our focus here was to define cigarette-use phenotypes that
have potential to be useful in genetic analyses. Reports
from the Collaborative Study on the Genetics of Alcohol-
ism (COGA) have shown that the "maximum number of
drinks ever consumed in a 24 hour period" is a useful phe-
notype for discovering potential genetic influences on
alcohol dependence [4].
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Methods
The cigarette smoking data consist of the number of ciga-
rettes smoked per day during periods of use in the year
prior to each exam. We have defined cigarette-use pheno-
types based on these available data. However, as the
exams were (generally) 2 years apart for the original
cohort and 4 years apart for the offspring cohort, it is pos-
sible that periods of smoking behavior could have been
missed. Furthermore, no information was available on
lifetime smoking, the duration of regular smoking over
the past year, or whether the subject was still currently
smoking at each exam.
We defined a maximum number of cigarettes phenotype
M, or MAXCIG, as the maximum cigarettes-per-day
reported over all the available exams (up to 18 exams with
cigarette data for the original cohort and 5 exams for the
offspring cohort). For the purposes of the descriptive
results below, the term "smokers" refers to individuals
with M > 0, and "non-smokers" refers to individuals with
M = 0. However, it is important to note that M is not the
same as true lifetime maximum use, which cannot be
determined from the longitudinal data provided.
For genetic analyses, the primary phenotype was taken to
be the maximum number of cigarettes phenotype where
individuals with M = 0 were excluded by recording their
phenotype as "unknown." From past experience with
alcohol phenotypes we expect that defining substance-
naive individuals to have unknown phenotype is most
appropriate, as individuals who have not been exposed to
a substance have unknown response; however, we also
performed parallel analyses that included M = 0 individu-
als for comparison. When M = 0 individuals are included,
we obtained 714 nuclear families with at least two pheno-
typed offspring, providing 1545 non-independent pheno-
typed and genotyped sib pairs. For the primary phenotype
(M = 0 considered unknown), there are 412 such nuclear
families, containing 621 non-independent phenotyped
and genotyped sib pairs.
Linear regression (using SAS, SAS Institute, Cary, NC) was
used to correct the primary maximum-cigarette pheno-
type for the significant covariate of gender in the initial
linkage analyses. Additional regression models adjusted
for both gender and year of birth (with linear and quad-
ratic terms and appropriate rescaling), both with and
without interaction terms. Each of the resulting pheno-
types was used for linkage analysis. Note that a similar
regression adjustment is not as appropriate in the case
where M = 0 individuals are included.
The original and offspring cohorts have different time
intervals between exams; this difference could lead to sys-
tematic differences in the resulting smoking phenotypes.
Thus we have compared maximum cigarette use when
sampling at 2-versus 4-year intervals in the original cohort
to examine whether this difference in time interval signif-
icantly affects the resulting phenotype.
Multi-point linkage analysis was carried out on all sib
pairs (n(n-1)/2 pairs for a sibship of size n) using Hase-
man-Elston regression as implemented in MAPMAKER/
SIBS [5].
We also examined descriptive birth cohort effects on M.
Since the exact year of birth was not directly given in the
data, we approximated year of birth as follows: for the
original cohort the age at first exam (age 1) was subtracted
from the starting year of the study (1948); for the off-
spring cohort, age at first exam was subtracted from 1971,
the starting year for the offspring recruitment. Using these
definitions, there were only five men and eight women in
the sample who were born in the 1960s (and none later),
so binned cohorts were defined by decades with the
youngest cohort having a birth year in the 1950s or later.
Results
In the full sample of original cohort and offspring cohort,
M ranged from 0 to 95. For this full sample, among smok-
ers the mean for M was 20.4 for females and 27.6 for
males.
We compared descriptive results for M for the original
cohort to the alternative phenotype Mo obtained from 4-
year exam intervals rather than 2-year intervals. Specifi-
cally, Mo is the maximum cigarettes-per-day reported over
all available odd-numbered exams (corresponding to
exam intervals of 4 years with 6 years between the first two
exams). Among men, 30.8% reported M = 0 versus 34.6%
who reported Mo = 0. Among women, 52.8% reported M
= 0 versus 55.0% with Mo = 0. Among smokers, a t-test
showed no significant difference between the means for M
and Mo in either gender. Hence the difference in the fre-
quency of exams between the two cohorts does not appear
to be a serious concern in defining M.
Sib-pair correlations were significant for M, consistent
with a familial trait. The correlations were 0.25 in male
pairs (p < 0.0001), 0.33 (p < 0.0001) in female pairs, and
0.13 (p = 0.002) in male-female pairs. Lower correlation
in male-female pairs compared to same-sex pairs has sim-
ilarly been observed for maximum alcohol consumption
traits [4].
Maximum cigarette use levels by gender and birth cohort
are presented in Table 1. In the regression analyses to
adjust M (with M = 0 recorded as missing) for covariate
effects, gender was highly significant (F = 115, p <
0.0001). Year of birth, tested with two degrees of freedom
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for the linear and quadratic terms, was also significant
when added to the model with gender (F = 25, p <
0.0001). Finally, including interaction terms was also sig-
nificant at the 0.05 level (F = 3.61, p = 0.027); this is con-
sistent with the pattern of effects in Table 1, which
indicates that the effect of birth cohort is somewhat differ-
ent for males than for females.
Linkage results are summarized in Table 2. Multi-point
linkage analyses of M corrected for gender (and M = 0
recorded as missing) resulted in LOD scores of 1.10 at 200
cM on chromosome 5, 1.67 at 173 cM on chromosome 9,
1.18 at 41 cM on chromosome 13, 1.29 at 87 cM on chro-
mosome 14, and 1.04 at 3 cM on chromosome 22. Results
for birth-year-adjusted analyses were very similar, with a
slight increase in LOD score for chromosome 9 (1.77 for
the full-model adjusted trait).
When nonsmokers were included in the analysis, linkage
results were substantially different from those of the pri-
mary analyses above: none of the above regions gave a
LOD above 1. Instead, LODs > 1 occurred on chromo-
somes 6, 8, 15, 17, and 20 (Table 2).
Discussion and Conclusions
The linkage results for these maximum use phenotypes are
modest. These phenotypes were constructed from the
available longitudinal data. The motivation for defining
M was that it provided a possible cigarette-use analog to
"maximum number of drinks in 24 hours"; linkage anal-
yses of this maximum drinks phenotype in data from the
Collaborative Study on the Genetics of Alcoholism
(COGA) indicated evidence for linkage to the region of
the alcohol dehydrogenase gene cluster on chromosome 4
[4].
Additional corrections for age effects in addition to sex
effects did not substantially affect the linkage analysis
results, even though age is clearly a significant covariate
for the maximum cigarette use phenotype studied. This
minimal impact on results could be due to the fact that
sib-pair based linkage analysis was performed; as siblings
tend to be similar in age, age-adjustment would tend to
have lesser effect on trait differences within pairs,
although scaling differences between sib pairs of different
cohorts still could have a meaningful effect.
Table 1: Maximum cigarette use (%) by birth cohortA
Born: Before 1920 1910s 1920s 1930s 1940s 1950s or later
Men
M = 0 38.67 21.11 27.21 28.19 38.70 52.67
1 ≤ M < 5 2.72 2.22 4.76 1.32 2.74 5.34
5 ≤ M < 10 3.32 1.48 1.36 0.88 2.40 2.29
10 ≤ M < 20 8.46 4.81 9.52 9.25 11.30 8.40
20 ≤ M < 30 27.19 24.07 21.77 24.23 17.81 11.45
30 ≤ M < 40 7.25 17.78 10.88 16.74 12.67 9.92
40 ≤ M < 50 9.06 20.00 12.93 13.66 9.59 7.63
50 ≤ M < 60 2.42 4.81 5.44 2.20 2.40 1.53
60 ≤ M < 70 0.91 3.70 4.76 3.08 2.40 0.76
70 ≤ M < 80 0 0 0 0 0 0
M ≥ 80 0 0 1.36 0.44 0 0
Total N 337 270 147 227 292 131
Women
M = 0 62.91 41.23 42.01 38.16 39.20 41.59
1 ≤ M < 5 4.45 4.31 5.33 2.63 4.65 12.39
5 ≤ M < 10 4.75 8.00 5.92 3.51 6.98 5.31
10 ≤ M < 20 5.93 12.92 7.10 13.60 11.30 9.73
20 ≤ M < 30 13.06 18.77 23.08 19.30 17.94 22.12
30 ≤ M < 40 5.93 6.46 8.28 12.72 11.30 5.31
40 ≤ M < 50 2.37 6.77 7.10 8.33 6.64 3.54
50 ≤ M < 60 0.59 0.92 0.59 0.88 1.33 0
60 ≤ M < 70 0 0.62 0.59 0.88 0.66 0
70 ≤ M < 80 0 0 0 0 0 0
M ≥ 80 0 0 0 0 0 0
Total N 337 325 169 228 301 113
AM = maximum cigarette use over all available examinations.
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There were substantial differences in results of the linkage
analyses for which M = 0 individuals were set to missing
compared with those for which M = 0 individuals were
included. The two phenotype definitions provide very dif-
ferent sample sizes, and while there are a similar number
of LOD scores over 1 for each phenotype, none occur in
the same regions (across the phenotypes). There are at
least two reasons why these differences in results may be
expected. First, M = 0 is being used as a proxy to recognize
substance-naïve individuals, some of whom might never-
theless be susceptible to heavy cigarette use if suitably
exposed; thus inclusion of these individuals with a trait
value of zero could substantially alter the phenotype, in
part from an effect similar to that of misdiagnosis, with
individuals sharing genetic susceptibility having errone-
ously dissimilar phenotype. Second, we see from Table 1
that the percentage of individuals with M = 0 is quite high,
and including these subjects with M = 0 not only increases
the sample size dramatically, but also forces a trait distri-
bution with properties very different from those of the dis-
tribution for M > 0 individuals only. Specifically, there is
a floor effect that is problematic for the distributional
requirements of regression analysis.
While Haseman-Elston regression is often described as a
"distribution-free" linkage method, this property is usu-
ally invoked when pointing out protection from false pos-
itives; it is worth noting that changes in and rescaling of a
trait's distribution will affect the power of an analysis to
detect a particular effect. We used classical Haseman-
Elston regression for our primary analyses due to concerns
about the distributions of the quantitative traits studied.
Besides Haseman-Elston regression, MAPMAKER/SIBS
can also be used to perform ML (maximum likelihood)
quantitative trait locus variance estimation on sib-pair
data. However, this method makes a necessary assump-
tion of normality in the distribution for sib pairs within
each identity-by-descent (IBD) class at a locus. ML vari-
ance estimation of the sample with M = 0 set to missing
did result in LOD scores that were at least partially sup-
portive of the Haseman-Elston findings (e.g., in sex-
adjusted analyses, LOD scores over 1 on chromosome 5
and chromosome 9 occurred in the same regions in Table
2, in addition to LODs over 1 on chromosomes 3 and 11).
However, when M = 0 subjects were included, results
peaked repeatedly throughout the genome, even when no
peaks were observed with Haseman-Elston regression. It
seems advisable to consider these latter ML variance
results (which included LOD scores above 5 on chromo-
somes 1, 11 and 20 in sex-adjusted analyses) not mean-
ingful due to the apparent violation of distributional
assumptions.
It should be noted that the maximum cigarette phenotype
M studied here would be expected to differ from pheno-
types obtained from direct questions such as "How many
cigarettes per day did you smoke during your heaviest
period of use" or "What is the largest number of cigarettes
you have ever smoked in a 24-hour period". Maximum or
quantitative cigarette-use phenotypes obtained from
Table 2: Linkage results from multi-point Haseman-Elston regression.A
Covariates
Sex Sex, YOBB, YOB2 Sex, YOB, YOB2, 
interactions
Chr Marker(s) cM LOD cM LOD cM LOD
M = 0 coded as 
missing
5 Mfd154-164xb8 200 1.10 200 1.08 200 1.02
9 308vb1-ATA59H06 173 1.67 172 1.78 172 1.77
13 GATA86H01-GATA6B07 41 1.18 41 1.11 41 1.28
13 GATA64F08-GATA7G10 - - - - 66 1.16
14 GGAA4A12-Mfd190 87 1.29 88 1.37 88 1.29
22 217xf4 3 1.04 3 1.05 3 1.06
M = 0 included
6 242zg5 182 1.47 179 1.27 181 1.49
8 ATA19G07-GAAT1A4 115 2.31 116 2.02 115 2.05
15 GATA85D02 - - 78 1.22 78 1.10
17 ATA78D02-GATA185H04 43 1.02 - - - -
20 GATA47F05-321xd1 81 1.15 81 1.21 80 1.13
ARegions with peak LOD > 1 for at least one phenotype definition are shown. BYOB, year of birth (as described in text).
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direct questions such as these may prove useful in other
studies. It also appears useful to include questions that
would permit direct identification of substance-naive or
minimally exposed individuals.
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